Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACSS2 | Q9NR19 | 8/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.42 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.36 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22630104 | 0.91 | GRIK2 (0.50) | ACSS2GRIK1GRIK2MTNR1AMTNR1B | |
| SCHEMBL21735554 | 0.90 | MTNR1A (0.44) | ACSS2GRIK1GRIK2MTNR1AMTNR1B | |
| SCHEMBL21735647 | 0.87 | KMT2A (0.43) | ACSS2MTNR1AMTNR1BNR1H2MCL1 | |
| SCHEMBL21735853 | 0.85 | MTNR1A (0.42) | ACSS2GRIK1GRIK2MTNR1AMTNR1B | |
| SCHEMBL21735550 | 0.84 | NR1H2 (0.39) | ACSS2MTNR1AMTNR1BNR1H2MCL1 | |
| SCHEMBL26292352 | 0.81 | GRIK2 (0.58) | ACSS2GRIK1GRIK2MTNR1AMTNR1B | |
| SCHEMBL21735703 | 0.79 | MTNR1A (0.46) | MTNR1AMTNR1BMCL1L3MBTL1 | |
| SCHEMBL22629969 | 0.78 | MTNR1A (0.40) | MTNR1AMTNR1BNR1H2MCL1L3MBTL1 | |
| SCHEMBL21735852 | 0.78 | NR1H2 (0.51) | NR1H2MCL1PDK2FGFR1SRC | |
| SCHEMBL21735689 | 0.76 | KMT2A (0.40) | MTNR1AMTNR1BNR1H2MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11014901-B2 | Hydrophobic compounds for optically active devices | MERCK PATENT GMBH (DE) | 2021-05-25 | — | — | US | disclosed |
| EP-3583091-B1 | HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH (DE) | 2020-11-04 | — | — | EP | disclosed |
| US-20200055833-A1 | HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH (DE) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200055833-A1 | HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | UACA, CRYZ, TRPA1 | ACSS2 3301/4885GRIK1 1873/4885GRIK2 2281/4885 |
| US-11014901-B2 | Hydrophobic compounds for optically active devices | UACA, CRYZ, TRPA1 | ACSS2 3301/4885GRIK1 1873/4885GRIK2 2281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.